This suggests that a correct dosage of HPF1 is important for proper balancing of various PARP1- and PARP2-catalysed reactions, and therefore subtler changes beyond simple loss-of-function might also be of therapeutic relevance in both cancer and other diseases. Here, PARP1 is linked to cancer.